PT73371B - A method for enhancing the yield of hepatitis a virus - Google Patents

A method for enhancing the yield of hepatitis a virus

Info

Publication number
PT73371B
PT73371B PT73371A PT7337181A PT73371B PT 73371 B PT73371 B PT 73371B PT 73371 A PT73371 A PT 73371A PT 7337181 A PT7337181 A PT 7337181A PT 73371 B PT73371 B PT 73371B
Authority
PT
Portugal
Prior art keywords
hepatitis
virus
enhancing
yield
hav
Prior art date
Application number
PT73371A
Other languages
English (en)
Portuguese (pt)
Other versions
PT73371A (en
Inventor
Henry Z Marcus
William J Mcaleer
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of PT73371A publication Critical patent/PT73371A/pt
Publication of PT73371B publication Critical patent/PT73371B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32451—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT73371A 1980-07-23 1981-07-15 A method for enhancing the yield of hepatitis a virus PT73371B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/171,621 US4301249A (en) 1980-07-23 1980-07-23 High titer production of hepatitis A virus

Publications (2)

Publication Number Publication Date
PT73371A PT73371A (en) 1981-08-01
PT73371B true PT73371B (en) 1983-06-15

Family

ID=22624494

Family Applications (1)

Application Number Title Priority Date Filing Date
PT73371A PT73371B (en) 1980-07-23 1981-07-15 A method for enhancing the yield of hepatitis a virus

Country Status (11)

Country Link
US (1) US4301249A (show.php)
EP (1) EP0044793B1 (show.php)
JP (1) JPS5753410A (show.php)
AT (1) ATE20250T1 (show.php)
CA (1) CA1187413A (show.php)
DE (1) DE3174765D1 (show.php)
DK (1) DK326781A (show.php)
ES (1) ES8205016A1 (show.php)
GR (1) GR74594B (show.php)
IE (1) IE51454B1 (show.php)
PT (1) PT73371B (show.php)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783407A (en) * 1985-09-30 1988-11-08 Merck & Co., Inc. Growth of hepatitus A virus in vero cells
DE3633550A1 (de) * 1986-10-02 1988-04-14 Behringwerke Ag Vaccine gegen hepatitis a
US5268292A (en) * 1988-06-27 1993-12-07 Robertson Betty H Reproducible generation of high yields of hepatitis A virus by cell culture
CA2098510A1 (en) * 1990-12-13 1992-06-14 Kenneth W. Culver Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy
US5506129A (en) * 1991-05-24 1996-04-09 Evans Medical Limited Virus production
DZ1706A1 (fr) * 1992-08-07 2002-02-17 Merck & Co Inc Vaccin contre le virus de l'hepatite a.
US5354692A (en) * 1992-09-08 1994-10-11 Pacific Biotech, Inc. Analyte detection device including a hydrophobic barrier for improved fluid flow
HRP950097A2 (en) * 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process
US5498537A (en) * 1994-03-09 1996-03-12 Cellco, Inc. Serum-free production of packaged viral vector
US20020182730A1 (en) * 1995-07-26 2002-12-05 Micheal L. Gruenberg Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
FR2821947B1 (fr) * 2001-03-12 2003-05-16 Canon Kk Procede et dispositif de validation de parametres definissant une image
US20030134415A1 (en) * 2001-09-19 2003-07-17 Gruenberg Micheal L. Th1 cell adoptive immunotherapy
US20030134341A1 (en) * 2001-09-19 2003-07-17 Medcell Biologics, Llc. Th1 cell adoptive immunotherapy
US20030175272A1 (en) * 2002-03-07 2003-09-18 Medcell Biologics, Inc. Re-activated T-cells for adoptive immunotherapy
US6872549B2 (en) * 2002-03-27 2005-03-29 Immunex Corporation Methods for increasing polypeptide production
JP5327793B2 (ja) * 2006-09-26 2013-10-30 国立大学法人京都大学 肝炎ウイルスの増殖方法、及びその利用
MX2009011899A (es) * 2007-05-04 2010-03-30 Baxter Int Perfil de temperatura de dos pasos para la propagacion de virus.
JP5692688B2 (ja) * 2008-06-26 2015-04-01 東洋紡株式会社 感染性ｃ型肝炎ウイルス粒子の製造方法、およびその利用
EP2686423A4 (en) 2011-03-14 2015-01-28 Nat Res Council Canada METHOD FOR PRODUCING VIRUSES IN CELLS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3615024A (en) * 1968-08-26 1971-10-26 Amicon Corp High flow membrane
US3821087A (en) * 1972-05-18 1974-06-28 Dedrick R Cell culture on semi-permeable tubular membranes
US3883393A (en) * 1972-05-18 1975-05-13 Us Health Education & Welfare Cell culture on semi-permeable tubular membranes
US3997396A (en) * 1973-07-02 1976-12-14 Monsanto Company Method for the in vitro propagation and maintenance of cells
US4087327A (en) * 1976-04-12 1978-05-02 Monsanto Company Mammalion cell culture process
FR2398504A1 (fr) 1977-07-29 1979-02-23 Tours Inst Virologie Culture de virus de l'hepatite a, in vitro. application a la production d'un antigene reactif, d'immunserums specifiques et de vaccins contre l'hepatite a
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro
US4301250A (en) * 1979-11-02 1981-11-17 Merck & Co., Inc. Method of producing hepatitis B surface antigen

Also Published As

Publication number Publication date
ES504199A0 (es) 1982-05-16
ES8205016A1 (es) 1982-05-16
EP0044793A3 (en) 1983-01-05
IE51454B1 (en) 1986-12-24
IE811655L (en) 1982-01-23
CA1187413A (en) 1985-05-21
PT73371A (en) 1981-08-01
DE3174765D1 (en) 1986-07-10
ATE20250T1 (de) 1986-06-15
US4301249A (en) 1981-11-17
GR74594B (show.php) 1984-06-29
EP0044793A2 (en) 1982-01-27
DK326781A (da) 1982-01-24
EP0044793B1 (en) 1986-06-04
JPS5753410A (en) 1982-03-30

Similar Documents

Publication Publication Date Title
PT73371A (en) A method for enhancing the yield of hepatitis a virus
KR870007282A (ko) 효모에서 b형 간염 바이러스 단백질을 제조하는 방법
IE882407L (en) Purifying hepatitis a virus
TR22917A (tr) Toprak disi tarima mahsus dayanak
DE3260046D1 (en) Method of producing hepatitis b surface antigen
SE7602751L (sv) Framstellning av n-acyl-l-metionin
ATE8409T1 (de) Verfahren zum vermehren menschlicher hepatitis-a viren in einer zellkultur in vitro.
DK461887A (da) Fremgangsmaade til selektivt at foroege andelen af enkelte hovedkomponenter af antibiotikum a 40926-kompleks
ATE10806T1 (de) Verfahren zur herstellung von hepatitis boberfl[chenantigen.
PT86619A (pt) Process for preparing alkylmelatonins
FI892683A7 (fi) Menetelmä ei-hyperglykosyloitujen hepatiitti-B-virusproteiinien tuottamiseksi
DK365387D0 (da) Fremgangsmaade ved fremstilling af biogas
IT8167770A0 (it) Procedimento per la produzione dil prolina per fermentazione
DK572181A (da) Fremgangsmaade til fremstilling af 3-oxo-delta1,4-steroider
DK260482A (da) Fremgangsmaade til fremstilling af rent hepatitis b overfladeantigen ud fra human plasma
FI903143A0 (fi) Menetelmä ihmisen nuhaviruksen serotyypittämiseksi
AU1668788A (en) Method of vaccination for hepatitis b virus
ATE86962T1 (de) Verfahren zur herstellung 1,4-disubstituierter 2- butene.
NO161274C (no) Fremgangsm te for fremstilling av immuninterferon.
ZA868611B (en) Fermentation methods for hepatitis vaccine production
DK0403015T3 (da) Fremgangsmåde til dyrkning af celler
DK541286A (da) Fermentationsmetoder for hepatitis-vaccinefremstilling
GR862720B (en) Fermentation methods for hepatitis vaccine production
SU1692147A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus l. - продуцент моноклональных антител к 146 s-компоненту вируса ящура cn 564
RO92552B1 (ro) Procedeu de obtinere a unei compozitii acrilice